Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.
Global daily coverage of all key events, customizable by country, sector or topics covering all key events
Special Reports (monthly)
Global and regional industry/market trends, drug class or therapeutic area news, biosimilars and generics developments, private insurance markets, and executive briefings on key global developments
Generics and Biosimilars
Approved and pipeline biosimilars, with analysis of litigation outcomes for top-selling branded pharmaceuticals in the United States
Daily updates for 65 countries, covering these topics:
Derived from world-renowned economic modeling, including:
|I need to understand new market entry risks and opportunities.||Use our Market Access Risk Scores (MARS) to assess complete entry risk in more than 65 countries.|
|How can I easily monitor multiple sources to keep pace with healthcare market trends?||Leverage our service to monitor competitors, R&D, investments, partnerships and regulatory issues.|
|I need to get a quick and accurate picture of a particular market.||Our SWOT tables, integrated into our country reports, provide a complete market overview, helping you plan with confidence.|
|I need to hedge my exposure in a contracting market.||Leverage forecasts to plan sales and budgets with greater accuracy. Distill our analysis and historical data to understand healthcare market drivers country-wide.|
|Generics and biosimilars are changing my market dynamics. How do I stay on top of these changes?||Access detailed data on the generics and biosimilars market, including pipeline and approved drugs. Stay informed with a litigation-tracking database.|
The evolution of insulin has undergone a tremendous change, from multiple injections routines to continuous subcutaneous insulin infusion through pumps. Pharmaceutical companies have been very active in inventing better methods of drug delivery, reducing the overall dose frequency and launching re-usable delivery systems. Unfortunately, two of the most powerful practices aren’t widely used: making lifestyle changes and adhering to regimens that regulate blood-sugar levels. These behaviors lower health costs and extend quality of life for diabetes patients, but patient buy-in has remained low on both.
Click sections below to explore current trends.
One of the world’s largest insurance companies expedites risk selection decisions to serve clients better by using best-in-class global information in its internal models. For instance, the firm gave 328 underwriters access to geo-political risk scores for every 500m2 sector of the earth’s surface and risk assessments for 6,400+ terrorist targets in 90 countries.Learn more about our customer’s success
One of the world’s largest oilfield service providers enhanced the forecasting accuracy of its oil rig count model from 90 to 97.6 percent, predicted the impact of price changes on customer spending and demand for product lines (by leveraging 3,500 factors) and created a model that predicted the deflation of WTI crude oil prices in late 2014.Learn More About Our Customers Success
This premier aircraft manufacturer produced Flying on Demand, Global Market Forecast 2014-2033, a reference book that provides comprehensive economic, financial and political coverage of 200-plus countries. Stakeholders throughout the commercial airline industry rely on the book’s insights regarding product innovation, production and planning.
A global insurance industry leader brought efficiency to risk selection by standardizing with one information provider across all underwriting decisions. This firm thereby reduced research costs by 20%, established a ‘center of excellence’ internally and fueled growth by gaining insights to write risk in areas where others held back.
New report predicts shortage of doctors in US. Coverage of our recent work: https://t.co/LxCbJa5l6n
International reference pricing: Love it or hate it, there is a good way and a bad way to do it https://t.co/T6t7dcwPby
Cross-country procurement: Will it soon be the bane of pharma's existence? https://t.co/H6R7l3m0gU
Three trends that will shape EU market access in the next decade https://t.co/sBmu4cZ5Pw
Follow World Markets Healthcare @IHS4LifeScience